Do oral microbiome changes meaningfully change infection risk?

How do oral microbiome changes actually raise infection risk?

The mouth is a major gateway for bacteria to enter the body. When the normal, balanced community of oral microbes is disrupted—a state called dysbiosis—harmful bacteria can overgrow and then spread to other sites. In leukemia patients, researchers found that the same bacteria causing dangerous bloodstream infections were often detectable at high levels in the mouth or stool beforehand [3]. This suggests the oral microbiome can act as a reservoir, seeding infections elsewhere. Similarly, in COVID-19 patients, the oral microbiome was significantly less diverse and had a different composition compared to healthy controls, with species like Prevotella salivae and Veillonella infantium being more common [7]. This dysbiosis was linked to a pro-inflammatory immune response, potentially making the body more susceptible to severe infection [7].

The mechanism is often microaspiration—tiny amounts of oral fluids containing bacteria are inhaled into the lungs. A systematic review of 20 studies found that poor oral health and dysbiosis were consistently associated with increased risk of lower respiratory tract infections, aspiration pneumonia, and ventilator-associated pneumonia [4]. The review noted that oral biofilms (plaque) harbor respiratory pathogens like Klebsiella and Pseudomonas, which can then seed the lungs [4]. Even in newborns, preterm infants showed delayed oral microbiome development and a higher abundance of virulence-associated genes, suggesting an early-life vulnerability to infection [8].

Who is most at risk from oral microbiome changes?

The risk is highest for people whose immune defenses are already compromised or who have had their microbiome disrupted by antibiotics. In a landmark phase 3 trial, patients with recurrent C. diff infection—a condition caused by antibiotic-driven gut microbiome disruption—who received an oral microbiome therapy (SER-109) had a recurrence rate of only 12%, compared to 40% in the placebo group [1]. This shows that restoring a healthy microbiome can directly prevent infection. The effect was even more dramatic in patients who had received the antibiotic fidaxomicin: the risk of recurrence dropped by 91% [1].

Leukemia patients are another high-risk group. In a study of 63 acute myeloid leukemia patients with bloodstream infections, the infecting bacteria were detectable in the mouth or stool in 78% of cases, even though only 7% showed the classic 'gut domination' pattern [3]. This means oral samples could be used to predict and personalize treatment for these vulnerable patients [3]. Elderly individuals also appear more susceptible: a meta-analysis found that older COVID-19 patients had a greater drop in oral microbiome diversity and lower expression of a key viral receptor (DPP4) in salivary glands, which may explain their higher risk of severe disease [2].

Even in generally healthy people, oral microbiome changes can matter. A study of cancer-free individuals found that those with high-risk oral HPV infection had a significantly different oral microbiome composition compared to HPV-negative controls, suggesting the microbiome may influence HPV persistence and cancer risk [5]. And in African Americans, while overall oral microbiome diversity wasn't linked to pancreatic cancer risk, known oral pathogens like Porphyromonas gingivalis showed elevated odds ratios among never-smokers [6].

Can you reduce infection risk by improving your oral microbiome?

Yes, the evidence strongly supports that improving oral hygiene and restoring a healthy microbiome can reduce infection risk, especially in high-risk settings. The systematic review on respiratory infections found that structured oral care—particularly daily toothbrushing and chlorhexidine mouthwash—significantly reduced pneumonia incidence in ICU and nursing home patients [4]. This is a practical, low-cost intervention that directly targets the oral microbiome as a source of pathogens.

For recurrent C. diff infection, the most effective approach is a microbiome-based therapy. The SER-109 trial showed that taking oral capsules containing purified Firmicutes spores after antibiotics reduced recurrence risk by 68% (from 40% to 12%) [1]. This therapy works by restoring bile acid profiles that inhibit C. diff spore germination [1]. While this specific treatment is for C. diff, the principle—that restoring a healthy microbiome can prevent infection—is broadly applicable.

For newborns, especially preterm infants, the evidence points to modifiable factors that shape the oral microbiome. Breastfeeding supported more stable microbial diversity, while cesarean delivery and formula feeding reduced diversity [8]. Prudent antibiotic use also helped [8]. These findings suggest that supporting a healthy oral microbiome from birth may reduce later infection risk.

About These Sources

This answer is built on 8 peer-reviewed studies — published from 2021 to 2025, 3 from 2024 or later, 7 in Q1 journals, collectively cited 609 times — selected as the most relevant from 9 studies that passed quality screening, drawn from 52 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions